07/23/2021, Moderna Inc. shares rose 7.84 percent in Friday trading

The daily tech stock news briefing

Content provided by Yi. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Yi or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3y ago 0:42

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on December 15, 2021 02:25 (2+ y ago). Last successful fetch was on July 28, 2021 11:05 (2+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Moderna Inc. shares rose 7.84 percent in Friday trading after the company announced that European regulators recommended approving its COVID-19 vaccine for teens as young as 12 years old. The recommendation was issued by the European Medicines Agency's Committee for Medicinal Products for Human Use; the final decision will be made by the European Commission. In the United States, Moderna's shot has not yet been approved for adolescent use. So far this year, the company's stock has risen 223.2 percent.

147 episodes

#Business News #News #Trading #Business #On Covid19